Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 07 Jun 2024 21:28:01 +0200Tue, 30 Apr 2024 13:09:00 +0200Human medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/lenvimaHuman medicines European public assessment report (EPAR): Lenvima, lenvatinib, Date of authorisation: 28/05/2015, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/lenvimaTue, 30 Apr 2024 13:09:00 +0200Human medicineLenvima : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-3727-en_1.pdfLenvima : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-3727-en_1.pdfThu, 18 Apr 2024 16:15:00 +0200Human medicine